176.967 articles found

Diagnostic Challenge in Bipolar I Disorder: Idiopathic Parkinson’s Disease vs. Antipsychotic-Induced Parkinsonism vs. Lithium Tremor

Adas S, Jetter E, Carr B.

European psychiatry : the journal of the Association of European Psychiatrists · 2026-09-04

Impulse control disorder in Parkinson’s disease: the influence of dopamine agonists

Varandas Rodrigues G, Pereira A.

European psychiatry : the journal of the Association of European Psychiatrists · 2026-09-04

Late-onset obsessive–compulsive phenomenology with parkinsonian features: a neuropsychiatric interface case

Cardoso Carrasqueira L.

European psychiatry : the journal of the Association of European Psychiatrists · 2026-09-04

Frontal stimulation reshapes SCAN connectivity and improves motor function in Parkinson’s disease

Check source for author details

bioRxiv : the preprint server for biology · 2026-09-04

An Unusual Case of a Hypopharyngeal Mass in a Patient Presenting With Weakness.

Mavilian CM, Yun J, Yu AC, Nguyen CT.

Case Rep Otolaryngol · 2026-09-04

DOI: 10.1155/crot/5553911PMID: 42699441

IL-34 in neurological homeostasis and its multifaceted roles in central nervous system diseases.

Xin Y, Liao Y, Cao X, Zhu X, Wang J.

Front Immunol · 2026-09-04

DOI: 10.3389/fimmu.2026.1860233PMID: 42761463

A mechanistically informed framework of hierarchical temporal speech organization for objective differential assessment of motor speech disorders in neurodegenerative diseases.

Bruning K, Heidrick L, Rong P.

Front Neurosci · 2026-09-04

DOI: 10.3389/fnins.2026.1907826PMID: 42761537

Local field potential biomarkers for adaptive deep brain stimulation in Parkinson's disease: A scoping review.

Khan RA, Imtiaz Ahamed MS, Thomas FJ, Bashier Mohamed BA, Balakumar B, Nasir M, Sarguroh Khan MAQ, Siraj HM.

Surg Neurol Int · 2026-09-04

DOI: 10.25259/sni_176_2026PMID: 42829632

Adult-Onset Levodopa-Unresponsive Parkinsonism as the Presenting Feature of Aromatic L-Amino Acid Decarboxylase Deficiency.

Spiteri M, Tilney R, Said E, Vella M.

Eur J Case Rep Intern Med · 2026-09-04

DOI: 10.12890/2026_007317PMID: 42877280

A new agent in the matrix: PINK1's expanded role in mitochondrial surveillance and regulation.

Collinson I, Corey RA, Grieve AG.

Autophagy · 2026-09-04

DOI: 10.1080/15548627.2026.2726091PMID: 42663105

Stimulation selectively blocks subthalamic high β-cortical high γ coupling in Parkinson's disease.

Berki ÁJ, Ding H, Palotai M, Halász L, Erőss L, Fekete G, Bognár L, Kelemen A, Jávor-Duray B, Pichner É, Babakhani AA, Muthuraman M, Tamás G.

Neurotherapeutics · 2026-09-04

DOI: 10.1016/j.neurot.2026.e01059PMID: 42691730

Glycolytic Reprogramming in Parkinson's Disease: From Bioenergetic Crosstalk to Therapeutic Modulation.

Yi Y, Chen C, He Y, Sun YZ, Cheng R, Liu MX, Liu ZG, Zhang XL.

Med Res Rev · 2026-09-04

DOI: 10.1002/med.70103PMID: 42695230